Lumeran, Xianley M.
HRN: 20-93-22 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/10/2022
AMPICILLIN 1GM (VIAL)
09/10/2022
09/16/2022
IVT
200
Q6
Bacterial Infection
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes